Skip to main content
Quest Diagnostics

Next-Generation Sequencing Panels for Cystic Kidney Disease with Improvements for Sequencing and Alignment Challenges

2022 ACMG (American College of Medical Genetics) Annual Clinical Genetics Meeting

March 22-26, 2022, Nashville, TN

Poster presentation: Next-Generation Sequencing Panels for Cystic Kidney Disease with Improvements for Sequencing and Alignment Challenges

Authors: Gall K, Hathaway J, Scocchia A,  Huusko J, Bernal M, Saarinen I, Rantanen M,  Schleit J,  Kangas-Kontio T,  Pietilä T, Salmenperä P Gentile M , Paananen J,  Myllykangas S,  Koskenvuo J

Specialties: Cardiovascular, Endocrinology, Genetics

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.